Upcoming Investments

Institutional investors including Armistice Capital, RTW Investments, and Wellington Management have increased their exposure to rare disease therapeutics companies as the orphan drugs market sustains strong growth momentum. Multiple specialized healthcare funds and broad-market asset managers allocated significant capital to the sector in 2024 and continue to do so in 2025, driven by accelerated FDA approvals and collaboration deals demonstrating commercial potential for treatments targeting small patient populations. The global rare disease treatment market value reached $224.30 billion in 2024, with some analysts projecting growth to $527 billion by 2034, a...

A new Texas law targeting land purchases by foreign nationals from China, Iran, North Korea and Russia is chilling real estate investment ahead of its September implementation, industry pros say. The vague language in the legislation has brokers and attorneys scrambling for clarity.Senate Bill 17, signed into law by Gov. Greg Abbott in June, will ban the purchase of real estate — including residential, commercial, industrial and agricultural — by entities tied to those four countries starting Sept. 1. It also prohibits related property interests such as leases longer than...